Arkema Completes Acquisition of Dow's Acrylic Monomers and Latex Business

As of January 25th 2010, Arkema formally completed its acquisition of Dow's Acrylic Monomers and Acrylic Latex Polymers (UCAR Emulsion Systems) business in North America.

Following this acquisition, the Clear Lakes (Texas) Acrylic Monomers production site is being integrated into the existing Acrylics business unit, within the Industrial Chemicals business segment.

The Acrylic Latex Polymers activity forms a new business unit dedicated to the paint, coatings, adhesives and construction product markets - Arkema Emulsion Systems. This new business unit will be part of the Industrial Chemicals business segment.

Richard Jenkins has been appointed Managing Director of this newly created business unit.

Arkema Emulsion Systems is headquartered in Cary (North Carolina, USA) and operates three latex production facilities in Torrance (California), Alsip (Illinois) and Hahnville (Louisiana). Research and development, marketing, sales and administration functions are located at the Cary, N.C. headquarters.

The PolyphobeTM Rheology modifiers formerly in the UCAR Emulsion Systems product line are being integrated into Arkema's Coatex subsidiary. By supplying PolyphobeTM products, Coatex will extend its portfolio for the Paint and Coatings industry to the United States, Canada, Mexico and Puerto Rico markets.

Richard Jenkins was previously the General Manager of Dow's UCAR Emulsions Systems and Monomers business; he has over 23 years of industry experience covering a range of technology, marketing, and business leadership positions both in North America and abroad.

He is graduated with a PhD in Chemical Engineering from Lehigh University in 1990 and has amassed 29 Patents and 70 publications of scientific papers to his credit throughout his career.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.